Failure of goserelin ovarian ablation in premenopausal women with breast cancer: Two case reports

Gynecologic Oncology

Volumn 76, Issue 1, 2000, Pages 126-127

  Jimenez Gordo A M ^a   De Las Heras, B ^a   Zamora, P ^a   Espinosa, E ^a   Gonzalez Baron M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Breast cancer; Goserelin; Ovarian ablation; Pregnancy; Premenopausal

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; GONADORELIN DERIVATIVE; GOSERELIN; METHOTREXATE; TAMOXIFEN; TRIPTORELIN;

ADULT; AMENORRHEA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; FEMALE; HORMONAL THERAPY; HORMONE RESISTANCE; HUMAN; PREGNANCY; PREMENOPAUSE; PRIORITY JOURNAL;

EID: 0343920671     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5641     Document Type: Article

References (11)

1. Tellez C, Craig Jordan V. Hormonal treatment of advanced breast cancer. Surg Oncol Clin North Am. 4:1995;751-777
2. Emons G, Schally A. The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers. Hum Reprod Update. 9:1994;1364-1379
3. Bajetta E, Celio L, Zilembo N, Bono A, Galluzzo D, Zampino M G, Longhi A, Ferrari L, Buzzoni R. Ovarian function suppression with the gonadotrophin-releasing hormone (GnRH) analogue goserelin in premenopausal advanced breast cancer. Tumori. 80:1994;28-32
4. Filicori M. Gonadotrophin-releasing hormone agonists. Drugs. 48:1994;41-58
5. Brambilla C, Escobedo A, Artioli R, Lechuga M J, Motta M. Treatment of pre-menopausal advanced breast cancer with goserelin - a long-acting luteinizing hormone releasing hormone agonist. Anti-Cancer Drugs. 3:1992;3-8
6. Lancet. 348:1996;1189-1196
7. Elefant E, Biour B, Blumberg-Tick J, Roux C, Thomas F. Administration of a gonadotropin-releasing hormone agonist during pregnancy: follow-up of 28 pregnancies exposed to triptoreline. Fertil steril. 63:1995;1111-1113
8. Pickersgill A, Kingsland C R, Garden A S, Farquharson R G. Multiple gestation following gonadotrophin releasing hormone therapy for the treatment of minimal endometriosis. Br J Obstet gynaecol. 101:1994;260-262
9. Cahill D J, Fountain S A, Fox R, Fleming C F, Brinsden P R, Hull M GR. Outcome of inadvertent administration of a gonadotrophin-releasing hormone agonist (Buserelin) in early pregnancy. Hum Reprod. 9:1994;1243-1246
10. Chang S Y, Soong Y K. Unexpected pregnancies exposed to leuprolide acetate administered after the mid-luteal phase for ovarian stimulation. Hum Reprod. 10:1995;204-206
11. Har-Toov J, Brenner S H, Jaffa A, Yavetz H, Peyser M R, Lessing J B. Pregnancy during long-term gonadotropin-releasing hormone agonist therapy associated with clinical pseudomenopause. Fertil Steril. 59:1993;446-447